|
ACTIONSIDE is providing innovative solutions to boost web business, using personalized behavioral analytics and dynamic behavioral marketing tools. |
|
Read more...
|
ANAGENESIS BIOTECHNOLOGIES aims to develop an innovative technological platform for the production of different tissue of lineage (muscle, dermis, bone, cartilage). These human differentiated cells are unique since they can be produced in a large amount of cells and allow a good prediction of human physiology.
These products address major needs, ranging from in vitro cellular models development for drug discovery and toxicity assays to regenerative medicine. |
|
Read more...
|
AXILUM ROBOTICS is a spin-off company from the medical robotics research group of LSIIT, a joint research unit of the University of Strasbourg, CNRS and INSA Strasbourg.
Its mission is to develop and commercialize dedicated robotized solutions to assist health care professionals with medical procedures.
The first product of AXILUM ROBOTICS is a robot designed to assist psychiatrists and neurologists for Transcranial Magnetic Stimulation, a noninvasive procedure for the treatment of various neurological and psychiatric disorders. |
|
Read more...
|
B4COM is tailoring adapted visual gestural codes to effectively communicate in emergency situations.
The first product is Tox Com®, a code specifically designed for rescuers operating under Chemical, Biological, Radiological, and Nuclear conditions. |
|
Read more...
|
BIONEXT is devoted to the development of high performance bioinformatics and chemo-informatics solutions for the life science industry and the academic research.
The company operates BVS™ (Bionext Virtual Screening), an integrated proprietary platform for the detection of molecular targets and anti-targets as well as their functional characterization in various cellular environments. |
|
Read more...
|
DEFYMED mission is to develop and market implantable bio-artificial medical devices for various therapeutic applications including liver, kidney, neurological and endocrine diseases.
The first company product is MAILPAN (MAcro-encapsulation of PANcreatic islets), a bio-artificial pancreas which has the potential to restore the physiological secretion of insulin in type 1 diabetes patients.
DEFYMED is a spin-off of the Strasbourg-based CeeD (Centre européen d’études du Diabète) Research Institute. |
|
Read more...
|
|
DROPLET DIAGNOSTICS is a biotechnological company focused on the development of highly sensitive diagnostic tests based on the microfluidics technology.
The first product of the company is a diagnostic test for the detection at very early stage of colon cancer. |
|
Read more...
|
EPIGEX proposes innovating tools for the research and development of epigenetic diseases encompassing cancer, inflammation, and auto-immune diseases.
The company portfolio includes molecular biology reagents for the screening of therapeutic compounds, a technology for the cartography of protein interaction impaired in epigenetic diseases and a set of new tumor biomarkers. |
|
Read more...
|
EPITOPOS is specialized in the development of innovative solutions (i.e. Laser-Induced Breakdown Spectroscopy) for the analysis of materials. It offers a set of services, including research and development, evaluation, analysis, characterization and consulting to the professionals of building and civil engineering, as well as cultural heritage.
EPITOPOS is a spin-off of the CRITT Matériaux Alsace (Regional Center for Innovation and Technology Transfer). |
|
Read more...
|
www.freshmile.com
FRESHMILE is an innovative mobility operator: it provides electric cars to end-users on a subscription basis. The service is designed to optimise the impact of electric vehicle charging on the electrical grid, by aggregating the load of the batteries and remote controlling their charging patterns.
The company is a spin-off from Novae Energies, a company developing renewable energy power plants. FRESHMILE is headquartered in Entzheim, near Strasbourg.
FRESHMILE leads the "Alsace Auto 2.0" pilot project, which will demonstrate the benefits of electric mobility applied to rural and peri-urban commuting. The Alsace Auto 2.0 project puts together a consortium of leading companies and universities and is supported by the local authorities.
|
|
Read more...
|
|
|
|
Fil de l'innovation
